Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA's Covaxin RejectionInvestorPlace • 03/04/22
Ocugen Provides an Update on its COVAXIN™ Pediatric (2-18) Emergency Use Authorization (EUA) RequestGlobeNewsWire • 03/04/22
Ocugen, Inc. (OCGN) CEO Shankar Musunuri on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/25/22
Ocugen's stock jumps 4% after saying FDA lifted hold on trial for experimental COVID-19 shotMarket Watch • 02/25/22
Ocugen Provides Business Update With Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 02/25/22
3 Growth Stocks With Monster Upside of 253% to 650%, According to Wall StreetThe Motley Fool • 02/24/22
Ocugen, Inc. Announces Pricing of $53.5 Million Public Offering of Common StockGlobeNewsWire • 02/23/22